Wockhardt
Wockhardt launches $40m manufacturing plant in Dubai
July 30, 2018Manufacturing and Production, Sales and Marketing Antibiotics, Dubai, India, Wockhardt, antibiotic resistance, pharma
Indian pharmaceutical firm Wockhardt has launched its first manufacturing facility in Dubai’s Jebel Ali Free Zone (Jafza). Costing $40 million, …
Wockhardt’s Gujarat plant hit with FDA warning letter
January 5, 2017Manufacturing and Production FDA, Wockhardt
Indian pharma and biotech firm Wockhardt has been accused of violating current good manufacturing practice (CGMP) regulations in a letter …
Wockhardt UK sterile site hit with FDA warning
November 29, 2016Manufacturing and Production FDA, Wockhardt, Wrexham
Mumbai-based pharmaceutical and biotechnology firm Wockhardt has been hit with more manufacturing woes as the FDA issued a warning letter …
FDA slaps import ban on Wockhardt facility
November 29, 2013Manufacturing and Production FDA, MHRA, Wockhardt, recall
The US Food and Drug Administration has banned imports of medicines made at Wockhardt’s Chikalthana plant in India that failed …
MHRA recalls five Wockhardt medicines
October 18, 2013Manufacturing and Production FDA, GMP, MHRA, Violations, Wockhardt, recall
The UK drugs regulator has recalled five more generic medicines made by Indian drugmaker Wockhardt after an inspection uncovered quality …
Manufacturing and production news in brief
September 6, 2013Manufacturing and Production GSK, Jabones Pardo, Mylan, Shasun, Wockhardt
A round-up of pharma manufacturing facility news, with updates from Wockhardt, Mylan, GSK and Shasun, plus an FDA warning letter …
FDA warning letter for troubled Wockhardt plant
July 23, 2013Manufacturing and Production FDA, Wockhardt, warning
The US regulator has issued a warning letter to a facility operated by Indian drugmaker Wockhardt already subject to an …
MHRA orders recall of Wockhardt drugs after import ban
July 11, 2013Manufacturing and Production MHRA, Wockhardt, recall
The UK regulatory authority has asked for a recall of medicines made at a Wockhardt facility in India, shortly after …
CP Pharma gets FDA warning for Wrexham facility
November 18, 2010Manufacturing and Production CP Pharmaceuticals, FDA, FDA warning letter, Wockhardt, manufacturing compliance, pharma manufacturing
UK drugmaker CP Pharmaceuticals is the latest to receive a warning letter from the FDA for failing to meet standards …
